Biden warns of GOP plans to curb access to health care
U.S. President Joe Biden will deliver a blistering criticism of Republican policies at a speech in Virginia Beach on Tuesday afternoon where he will warn of GOP plans to cut access to federal health-care programs.Speaking at the Kempsville Recreation Center, Biden will point to GOP proposals to repeal the Affordable Care Act and cut funding […]
Omicron subvariant that’s dominant in U.S. extends lead over other variants in latest week, CDC data shows
The omicron subvariant that became dominant in the U.S. several weeks ago continued to extend its lead over other variants in the latest week, according to Centers for Disease Control and Prevention data that was updated on Friday. XBB.1.5, the omicron sublineage that first emerged in small numbers in October, accounted for 66.4% of cases […]
This trader nailed two big market calls in 2022. She says investors are ‘being paid to wait’ so should steer clear of stocks for 2023.
Ahead of major tech earnings, Meta results are ready to light up the Nasdaq Composite COMP for Thursday. The S&P 500 SPX is also pointing to gains as investors take a glass-half full view of the Fed meeting. Worried that investors are in the clutches of another Fed misread is the founder of LaDucTrading.com, Samantha LaDuc. “The […]
Pandemic is still a global health emergency but it may be reaching a point where higher immunity levels mean fewer deaths
The coronavirus pandemic is still a global health emergency, according to the World Health Organization, but an advisory panel has determined that it may be nearing an inflection point where higher levels of immunity will lead to fewer deaths. That was the message Monday from WHO Director-General Tedros Adhanom Ghebreyesus at the agency’s annual executive […]
One of the greatest cancer drugs lost its edge. This is why it was vulnerable.
In November, British-Swedish drug giant AstraZeneca published a simple chart in its quarterly earnings presentation that the pharmaceutical industry never saw coming. It showed that 55% of chronic lymphocytic leukemia patients in the U.S. were choosing Calquence, and not Imbruvica, the long-time leading treatment for the disease, when being prescribed a class of drug known […]
Opinion: Cognitive decline in a loved one: how to spot it, what to do
Both as a financial adviser and in my prior role as an attorney, I’ve seen families struggle with cognitive decline of an aging parent. Financial and estate planning can’t take away the heartache, but they can help families avoid some wrenching situations.In this article, I’ll share two scenarios drawn from real-life circumstances I’ve observed. One […]
The 1980s was the blueprint for the upcoming disinflation cycle and these are the stocks for it, strategists say
Stocks are setting up for a third straight losing session after data sparked fears that the economy is losing steam, while the Fed pushes on with interest rate hikes. Or as CNBC commentator Ron Insana put it:On that front, our call of the day from Jefferies tackles that idea. “Disinflation is a key assumption for […]
How a ‘triple-barreled buy signal’ and other green flags could send the S&P 500 20% higher, says this money manager
A holiday-shortened week is looking like it will get off to a lower start, as China landed some weak growth numbers and more earnings roll out. That’s after two positive weeks to start 2023. But there’s more than a whiff of bullishness in the air, according to our call of the day, from investment research […]
Eating these simple foods may slow Alzheimer’s by a third
Biogen’s new Alzheimer’s drug lecanemab has gotten the headlines recently. But it’s not the only good news on the dementia front. Far from it. Some might even say we’re making as much progress, or more, outside the drug labs as inside. I’ve already written about the power of walking, crosswords, and meditation to lower your […]
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
Drug companies planning to raise prices on cancer drugs and other life-saving treatments are justifying the move by claiming it’s necessary to fund research and development, but the claim rings hollow given that they spend more on shareholder rewards than on R&D, according to a new study. Accountable.US, a liberal-leaning consumer-advocacy group, found that in […]